AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $877,000 | -36.2% | 31,000 | -50.0% | 0.00% | -50.0% |
| Q2 2022 | $1,375,000 | -47.5% | 62,000 | -17.1% | 0.00% | -33.3% |
| Q3 2020 | $2,618,000 | -33.2% | 74,800 | -38.2% | 0.00% | 0.0% |
| Q3 2019 | $3,920,000 | +56.2% | 121,000 | +140.6% | 0.00% | +50.0% |
| Q2 2019 | $2,509,000 | -55.6% | 50,300 | -27.2% | 0.00% | -33.3% |
| Q2 2018 | $5,651,000 | 0.0% | 69,100 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $5,651,000 | +479.6% | 69,100 | +334.6% | 0.01% | +100.0% |
| Q3 2014 | $975,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |